Skip to main content
. 2020 Oct 8;61:103026. doi: 10.1016/j.ebiom.2020.103026

Table 2.

Predictive performance of the models studied.

Predictor MSE MAE RPS Improved AUC Declined AUC
Biomarker Timing
IL-6:IL-10 Slope over study 0.20 0.20 0.15 0.981 0.958
IL-6:IL-10 D4 - D0 0.35 0.30 0.23 0.927 0.928
IL-6 Slope over study 0.45 0.35 0.26 0.877 0.888
IL-6 D4 - D0 0.78 0.50 0.39 0.801 0.829
IL-6:IL-10 D2 - D0 0.83 0.53 0.38 0.827 0.866
IL-6 D2 - D0 1.33 0.78 0.45 0.731 0.746
IL-6 Admission (D0) 1.53 0.88 0.46 0.724 0.702
IL-6:IL-10 Admission (D0) 1.53 0.88 0.46 0.727 0.706
Dublin-Boston score 0.39 0.34 0.22 0.921 0.897

IL – interleukin.

MSE – mean squared error.

MAE – mean absolute error.

RPS – ranked probability score.

Improved AUC – area under the curve for predicting the binary outcome of whether the patient improved or not.

Declined AUC – area under the curve for predicting the binary outcome of whether the patient declined or not.

D – Hospital day.